Vision Ophthalmology Group Acquires MED Medical Products GmbH

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

October 9, 2018: Vision Ophthalmology Group announced today the acquisition of MED Medical Products GmbH effective immediately.

MED Medical Products is a specialist producer of customized procedure packs and disposable products used in ophthalmic surgery based in Karlstein, Germany and was founded in 1997.

MED will operate as an independent business within VOG under the leadership of the current management team of Thomas Neumann (Managing Director) and Hariet Dörling (Customer Service Manager). MED will continue to serve its customers with dedication and quality as it always has.

“The acquisition of MED strengthens our value chain, extends our service portfolio and continues the growth of our business. And it enables VOG to enhance its offering to ophthalmologists across Europe” said Roland Bruhin, CEO of VOG.

spot_img

DON'T MISS

Related Articles